Infusion

A medicine given slowly through a drip into a vein, usually in hospital.

Also called: iv, intravenous, intravenous infusion, drip, infusion unit

Related words subcutaneous injection

Topics Biologics and newer medicines

Questions people ask

What is upadacitinib (Rinvoq) and how is it different from biologics?

Upadacitinib is a tablet that belongs to a group called JAK inhibitors. It blocks proteins inside cells that switch on the immune response, rather than being an antibody given by drip or injection. Trials found it worked better than placebo for moderate to severe Crohn's, and NICE recommends it after a biologic has failed or when anti-TNFs are unsuitable. Shingles was more common in people taking it.

Sources

What is a biologic medicine?

Crohn's & Colitis UK explains that biologics are antibody medicines made by living cells in a lab. Each one targets a specific part of the immune system involved in inflammation: anti-TNFs (infliximab, adalimumab), the anti-integrin vedolizumab, and interleukin blockers (ustekinumab, risankizumab, mirikizumab, guselkumab). They are given by drip or by injection under the skin. Upadacitinib is a 'targeted' tablet, not a biologic.

Sources

Why do people with Crohn's get anaemia, and how is it treated?

Crohn's & Colitis UK says iron deficiency anaemia is common in Crohn's, caused by blood loss from the gut, poor absorption or too little iron in the diet. Symptoms include tiredness, breathlessness, headaches and pale skin, says the NHS. Treatment may be iron tablets or iron given into a vein; a Cochrane review found iron through a drip probably helps more people than tablets.

Sources

Where to read more

Infliximab

Crohn's & Colitis UK Guide Jun 2024 For patients

A guide to infliximab, an anti-TNF biologic given by drip or as an injection under the skin. It lists the original brand Remicade and biosimilars such as Remsima, Inflectra, Flixabi and Zessly, and explains checks before starting, that your team may measure drug and antibody levels in your blood, and possible side effects.

Topics Biologics and newer medicines Monitoring

Jargon explained anti-TNF infusion subcutaneous biosimilar drug levels antibodies

Starting biologic medication

Royal Free London NHS Foundation Trust Leaflet Aug 2025 For patients

A patient leaflet for people starting a biologic for IBD. It explains what biologics are, when they are used (often after steroids or azathioprine have not worked), and lists the biologics used at the hospital, their brands and how each is given.

Topics Biologics and newer medicines

Jargon explained biologic infusion biosimilar

Interventions for treating iron deficiency anaemia in inflammatory bowel disease

Cochrane Systematic review Jan 2021 Patients and professionals

Looks at iron tablets and iron drips for anaemia caused by low iron in IBD. The reviewers found the evidence too weak to say for certain which works best, even though both are widely used and guidelines favour drips. They highlight this as an important gap.

Topics Anaemia Research

Jargon explained iron deficiency anaemia intravenous iron ferric carboxymaltose

British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults

Gut (British Society of Gastroenterology) Guideline Nov 2021 For professionals

The BSG guideline on iron deficiency anaemia. It explains that the gut is a common source of the blood loss or poor absorption behind it, and that good care means both replacing iron (by mouth or drip) and finding the cause.

Topics Anaemia Diagnosis and tests

Jargon explained iron deficiency anaemia intravenous iron

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease (UNITI)

New England Journal of Medicine Study Nov 2016 Patients and professionals

The trials that led to ustekinumab (Stelara) being used for Crohn's. A first drip of ustekinumab helped more people improve than a dummy drip, and injections every 8 or 12 weeks afterwards kept about half of responders in remission at week 44, against about 36% on placebo. Side effects were similar between groups.

Topics Biologics and newer medicines

Jargon explained induction maintenance IL-12/23 placebo

Guselkumab

Crohn's & Colitis UK Guide Dec 2025 For patients

A guide to guselkumab (Tremfya), an IL-23 blocking medicine. The first three doses can be a drip or an injection, after which it is injected under the skin; the page covers vaccines and side effects.

Topics Biologics and newer medicines

Jargon explained IL-23 interleukin inhibitor

Risankizumab

Crohn's & Colitis UK Guide Jul 2023 For patients

A guide to risankizumab (Skyrizi), a biologic that blocks the IL-23 protein involved in inflammation. You start with a few drips, then have regular injections under the skin; the page explains trial results and side effects.

Topics Biologics and newer medicines

Jargon explained IL-23 interleukin biologic

Search everything for "infusion"